662116-66-7Relevant articles and documents
Identification of azabenzimidazoles as potent JAK1 selective inhibitors
Vasbinder, Melissa M.,Alimzhanov, Marat,Augustin, Martin,Bebernitz, Geraldine,Bell, Kirsten,Chuaqui, Claudio,Deegan, Tracy,Ferguson, Andrew D.,Goodwin, Kelly,Huszar, Dennis,Kawatkar, Aarti,Kawatkar, Sameer,Read, Jon,Shi, Jie,Steinbacher, Stefan,Steuber, Holger,Su, Qibin,Toader, Dorin,Wang, Haixia,Woessner, Richard,Wu, Allan,Ye, Minwei,Zinda, Michael
, p. 60 - 67 (2015/12/18)
We have identified a class of azabenzimidazoles as potent and selective JAK1 inhibitors. Investigations into the SAR are presented along with the structural features required to achieve selectivity for JAK1 versus other JAK family members. An example from
2-PHENYL-3H-IMIDAZO[4,5-B]PYRIDINE DERIVATES USEFUL AS INHIBITORS OF MAMMALIAN TYROSINE KINASE ROR1 ACTIVITY
-
, (2016/09/22)
A compound of formula (I′) or (I′′) or a pharmaceutically acceptable salt thereof. The compound is an inhibitor of mammalian kinase enzyme activity, including ROR1 tyrosine kinase activity and may be used in the treatment of disorders associated with such activity.
Hit generation and exploration: Imidazo[4,5-b]pyridine derivatives as inhibitors of Aurora kinases
Bavetsias, Vassilios,Sun, Chongbo,Bouloc, Nathalie,Reynisson, Johannes,Workman, Paul,Linardopoulos, Spiros,McDonald, Edward
, p. 6567 - 6571 (2008/04/03)
A hit generation and exploration approach led to the discovery of 31 (2-(4-(6-chloro-2-(4-(dimethylamino)phenyl)-3H-imidazo[4,5-b]pyridin-7-yl)piperazin-1-yl)-N-(thiazol-2-yl)acetamide), a potent, novel inhibitor of Aurora-A, Aurora-B and Aurora-C kinases